Bionano Sets Revenue Target of $30M-$33M for 2026, Focusing on User Growth and Margin Expansion

Bionano Genomics is targeting $30M-$33M in revenue by 2026, with a focus on routine user growth and margin expansion. The company aims to transform pathology workflows with digital, automated, and AI-driven solutions, citing hundreds of publications and presentations by users in 2025 as evidence of progress. Management is optimistic about the future, with CEO Robert Holmlin framing the company's mission as a key driver of growth.